Saturna Capital CORP Maintains Holdings in CVS Health Corporation (CVS)

Saturna Capital CORP maintained its stake in CVS Health Corporation (NYSE:CVS) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,035 shares of the pharmacy operator’s stock at the end of the 1st quarter. Saturna Capital CORP’s holdings in CVS Health Corporation were worth $1,023,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its stake in shares of CVS Health Corporation by 3.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after purchasing an additional 5,478 shares in the last quarter. Naples Global Advisors LLC bought a new stake in shares of CVS Health Corporation during the 1st quarter worth approximately $452,000. Candriam Luxembourg S.C.A. raised its stake in shares of CVS Health Corporation by 17.9% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 92,139 shares of the pharmacy operator’s stock worth $7,233,000 after purchasing an additional 14,012 shares in the last quarter. British Columbia Investment Management Corp raised its stake in shares of CVS Health Corporation by 3.7% during the 1st quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock worth $44,062,000 after purchasing an additional 19,794 shares in the last quarter. Finally, Northern Capital Management LLC raised its stake in shares of CVS Health Corporation by 15.5% during the 1st quarter. Northern Capital Management LLC now owns 43,455 shares of the pharmacy operator’s stock worth $3,411,000 after purchasing an additional 5,830 shares in the last quarter. Institutional investors own 81.55% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded up 2.46% on Tuesday, reaching $81.68. The company’s stock had a trading volume of 2,441,214 shares. The firm’s 50 day moving average is $78.37 and its 200-day moving average is $78.89. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $91.82. The stock has a market cap of $83.03 billion, a P/E ratio of 16.27 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same period in the prior year, the business earned $1.32 EPS. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Corporation will post $5.88 EPS for the current year.

A number of equities research analysts have recently issued reports on CVS shares. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $85.96 price objective on the stock in a research note on Wednesday, May 17th. ValuEngine cut CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a research note on Sunday. BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Finally, Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $90.83.

In other news, Director Richard J. Swift sold 2,500 shares of the company’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the completion of the transaction, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Helena Foulkes sold 20,333 shares of the company’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $80.00, for a total value of $1,626,640.00. Following the completion of the transaction, the executive vice president now owns 59,301 shares of the company’s stock, valued at $4,744,080. The disclosure for this sale can be found here. Insiders sold a total of 43,165 shares of company stock valued at $3,390,847 over the last quarter. Company insiders own 0.61% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/2886892/saturna-capital-corp-maintains-holdings-in-cvs-health-corporation-cvs.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.